Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction

Open access
Bum-Erdene, Khuchtumur, Zhou, Donghui, Gonzalez-Gutierrez, Giovanni, Ghozayel, Mona K., Si, Yubing, Xu, David, Shannon, Harlan E., Bailey, Barbara J., Corson, Timothy W., Pollok, Karen E., Wells, Clark D., Meroueh, Samy O.·2019·Cell Chemical Biology

Abstract

The Hippo pathway coordinates extracellular signals onto the control of tissue homeostasis and organ size. Hippo signaling primarily regulates the ability of Yap1 to bind and co-activate TEA domain (TEAD) transcription factors. Yap1 tightly binds to TEAD4 via a large flat interface, making the development of small-molecule orthosteric inhibitors highly challenging. Here, we report small-molecule TEAD⋅Yap inhibitors that rapidly and selectively form a covalent bond with a conserved cysteine located within the unique deep hydrophobic palmitate-binding pocket of TEADs. Inhibition of TEAD4 binding to Yap1 by these compounds was irreversible and occurred on a longer time scale. In mammalian cells, the compounds formed a covalent complex with TEAD4, inhibited its binding to Yap1, blocked its transcriptional activity, and suppressed expression of connective tissue growth factor. The compounds inhibited cell viability of patient-derived glioblastoma spheroids, making them suitable as chemical probes to explore Hippo signaling in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2018.11.010

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 56

  1. Anbanandam, 2006, Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain, Proc. Natl. Acad. Sci. U S A, 103, 17225, 10.1073/pnas.0607171103 · DOI
  2. Aragona, 2013, A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors, Cell, 154, 1047, 10.1016/j.cell.2013.07.042 · DOI · Paper page
  3. Artinian, 2015, Phosphorylation of the Hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness, J. Biol. Chem., 290, 19387, 10.1074/jbc.M115.656587 · DOI
  4. Banks, 2005, Integrated modeling program, applied chemical theory (IMPACT), J. Comput. Chem., 26, 1752, 10.1002/jcc.20292 · DOI · Paper page
  5. Bayly, 2013, A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model, J. Phys. Chem., 97, 10269, 10.1021/j100142a004 · DOI · Paper page
  6. Brooks, 1983, Harmonic dynamics of proteins: normal modes and fluctuations in bovine pancreatic trypsin inhibitor, Proc. Natl. Acad. Sci. U S A, 80, 6571, 10.1073/pnas.80.21.6571 · DOI · Paper page
  7. Chen, 2010, Structural basis of YAP recognition by TEAD4 in the hippo pathway, Genes Dev., 24, 290, 10.1101/gad.1865310 · DOI · Paper page
  8. Chen, 2018, Small-molecule CaVα1·CaVβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking, Proc. Natl. Acad. Sci. U.S.A., 115, 10.1073/pnas.1813157115 · DOI
  9. Darden, 1993, Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems, J. Chem. Phys., 98, 10089, 10.1063/1.464397 · DOI · Paper page
  10. Donohue, 2014, Induction of covalently crosslinked p62 oligomers with reduced binding to polyubiquitinated proteins by the autophagy inhibitor verteporfin, PLoS One, 9, e114964, 10.1371/journal.pone.0114964 · DOI · Paper page
  11. Donohue, 2013, The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model, J. Cancer, 4, 585, 10.7150/jca.7030 · DOI
  12. Donohue, 2011, Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin, J. Biol. Chem., 286, 7290, 10.1074/jbc.M110.139915 · DOI
  13. Eldridge, 1997, Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Comput. Aided Mol. Des., 11, 425, 10.1023/A:1007996124545 · DOI · Paper page
  14. Emsley, 2010, Features and development of Coot, Acta Crystallogr D. Biol. Crystallogr., D66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  15. Fan, 2013, Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1, Proc. Natl. Acad. Sci. U S A, 110, 2569, 10.1073/pnas.1216462110 · DOI · Paper page
  16. Feig, 2004, Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures, J. Comput. Chem., 25, 265, 10.1002/jcc.10378 · DOI · Paper page
  17. Fitamant, 2015, YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression, Cell Rep., 10, 1692, 10.1016/j.celrep.2015.02.027 · DOI · Paper page
  18. Fridell, 1996, Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase, Mol. Cell. Biol., 16, 135, 10.1128/MCB.16.1.135 · DOI · Paper page
  19. Greenwood, 2010, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, J. Comput. Aided Mol. Des., 24, 591, 10.1007/s10822-010-9349-1 · DOI · Paper page
  20. Hong, 2012, The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway, Semin. Cell Dev. Biol., 23, 785, 10.1016/j.semcdb.2012.05.004 · DOI · Paper page
  21. Jacobson, 2004, A hierarchical approach to all-atom protein loop prediction, Proteins, 55, 351, 10.1002/prot.10613 · DOI · Paper page
  22. Jiao, 2014, A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer, Cancer Cell, 25, 166, 10.1016/j.ccr.2014.01.010 · DOI · Paper page
  23. Jorgensen, 1983, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys., 79, 926, 10.1063/1.445869 · DOI · Paper page
  24. Li, 2010, Structural insights into the YAP and TEAD complex, Genes Dev., 24, 235, 10.1101/gad.1865810 · DOI · Paper page
  25. Liu-Chittenden, 2012, Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP, Genes Dev., 26, 1300, 10.1101/gad.192856.112 · DOI · Paper page
  26. Maier, 2015, ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput., 11, 3696, 10.1021/acs.jctc.5b00255 · DOI · Paper page
  27. Mani, 2013, Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor, ChemMedChem, 8, 1963, 10.1002/cmdc.201300340 · DOI
  28. Mauviel, 2012, Integrating developmental signals: a Hippo in the (path)way, Oncogene, 31, 1743, 10.1038/onc.2011.363 · DOI
  29. McWeeny, 1968, Self-consistent perturbation theory. II. extension to open shells, J. Chem. Phys., 49, 4852, 10.1063/1.1669970 · DOI · Paper page
  30. Mesrouze, 2017, Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ, Protein Sci., 26, 2399, 10.1002/pro.3312 · DOI
  31. Miller, 2012, MMPBSA.py: an efficient program for end-state free energy calculations, J. Chem. Theory Comput., 8, 3314, 10.1021/ct300418h · DOI · Paper page
  32. Noland, 2016, Palmitoylation of TEAD transcription factors is required for their stability and function in hippo pathway signaling, Structure, 24, 179, 10.1016/j.str.2015.11.005 · DOI · Paper page
  33. Olsson, 2011, PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions, J. Chem. Theory Comput., 7, 525, 10.1021/ct100578z · DOI · Paper page
  34. Onufriev, 2004, Exploring protein native states and large-scale conformational changes with a modified generalized born model, Proteins, 55, 383, 10.1002/prot.20033 · DOI · Paper page
  35. Orr, 2011, Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth, J. Neuropathol. Exp. Neurol., 70, 568, 10.1097/NEN.0b013e31821ff8d8 · DOI · Paper page
  36. Petersson, 1988, A complete basis set model chemistry. I. The total energies of closed-shell atoms and hydrides of the first-row elements, J. Chem. Phys., 89, 2193, 10.1063/1.455064 · DOI · Paper page
  37. Piccolo, 2013, Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis, Clin. Cancer Res., 19, 4925, 10.1158/1078-0432.CCR-12-3172 · DOI
  38. Pobbati, 2012, Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes, Structure, 20, 1135, 10.1016/j.str.2012.04.004 · DOI · Paper page
  39. Pobbati, 2015, Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy, Structure, 23, 2076, 10.1016/j.str.2015.09.009 · DOI · Paper page
  40. Pobbati, 2013, Emerging roles of TEAD transcription factors and its coactivators in cancers, Cancer Biol. Ther., 14, 390, 10.4161/cbt.23788 · DOI · Paper page
  41. Pople, 1954, Self-consistent orbitals for radicals, J. Chem. Phys., 22, 571, 10.1063/1.1740120 · DOI · Paper page
  42. Reddy, 2013, Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins, Dev. Cell, 24, 459, 10.1016/j.devcel.2013.01.020 · DOI · Paper page
  43. Roe, 2013, PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput., 9, 3084, 10.1021/ct400341p · DOI · Paper page
  44. Rosell, 2013, Genetics and biomarkers in personalisation of lung cancer treatment, Lancet, 382, 720, 10.1016/S0140-6736(13)61715-8 · DOI · Paper page
  45. Ryckaert, 1977, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes, J. Comput. Phys., 23, 327, 10.1016/0021-9991(77)90098-5 · DOI · Paper page
  46. Sastry, 2013, Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments, J. Comput. Aided Mol. Des., 27, 221, 10.1007/s10822-013-9644-8 · DOI · Paper page
  47. Shah, 2014, Cs-31a novel yap-driven migration and invasion signaling pathway predicts poor outcome in glioblastoma, Neuro Oncol., 16, v57, 10.1093/neuonc/nou242.31 · doi:10.1093/neuonc/nou242.31
  48. Shelley, 2007, Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules, J. Comput. Aided Mol. Des., 21, 681, 10.1007/s10822-007-9133-z · DOI · Paper page
  49. Still, 1990, Semianalytical treatment of solvation for molecular mechanics and dynamics, J. Am. Chem. Soc., 112, 6127, 10.1021/ja00172a038 · DOI · Paper page
  50. Toledo Warshaviak, 2014, Structure-based virtual screening approach for discovery of covalently bound ligands, J. Chem. Inf. Model., 54, 1941, 10.1021/ci500175r · DOI
  51. Wang, 2004, Development and testing of a general amber force field, J. Comput. Chem., 25, 1157, 10.1002/jcc.20035 · DOI · Paper page
  52. Wu, 2003, Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts, Cell, 114, 445, 10.1016/S0092-8674(03)00549-X · DOI · Paper page
  53. Yu, 2013, The Hippo pathway: regulators and regulations, Genes Dev., 27, 355, 10.1101/gad.210773.112 · DOI · Paper page
  54. Zhang, 2014, VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex, Cell Res., 24, 331, 10.1038/cr.2014.10 · DOI · Paper page
  55. Zhao, 2008, TEAD mediates YAP-dependent gene induction and growth control, Genes Dev., 22, 1962, 10.1101/gad.1664408 · DOI · Paper page
  56. Zhou, 2015, Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides, FASEB J., 29, 724, 10.1096/fj.14-262980 · DOI

Cited by

See all 193

Metadata

Authors
Bum-Erdene, K., Zhou, D., Gonzalez-Gutierrez, G., Ghozayel, M. K., Si, Y., Xu, D., Shannon, H. E., Bailey, B. J., Corson, T. W., Pollok, K. E., Wells, C. D., & Meroueh, S. O.
Venue
Cell Chemical Biology
Publisher
Elsevier BV
Published
2019-03
Volume
26
Issue
3
Pages
378-389.e13
ISSN
  • 2451-9448 (ISSN-L)
  • 2451-9456
OpenAlex
W2906608599
Cited by
193
References
5
FWCI
5.97
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • American Cancer Society Research Scholar (RSG-12-092-01-CDD)
  • Indiana Drug Discovery Alliance
  • Vera Bradley Foundation
  • Indiana University
  • Lilly Endowment
  • Indiana University Pervasive Technology Institute
  • Indiana METACyt Initiative

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction. https://app.cochat.ai/papers/10.1016/j.chembiol.2018.11.010
The paper
Bum-Erdene, K., Zhou, D., Gonzalez-Gutierrez, G., Ghozayel, M. K., Si, Y., Xu, D., Shannon, H. E., Bailey, B. J., Corson, T. W., Pollok, K. E., Wells, C. D., & Meroueh, S. O. (2019). Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2018.11.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.